.

Ptc Therapeutics reported $-92362000 in Operating Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -33.65M 79.36M
Alnylam Pharmaceuticals ALNY:US $ -191.69M 44.95M
Amgen AMGN:US $ 2176M 324M
Biocryst Pharmaceuticals BCRX:US $ -34.72M 15.24M
Biogen BIIB:US $ -59.1M 669.8M
Biomarin Pharmaceutical BMRN:US $ 39.15M 98.18M
Bluebird Bio BLUE:US $ -107.4M 12.95M
Cytokinetics CYTK:US $ -10.87M 69.68M
Daiichi Sankyo 4568:JP Y 34382M 85129M
Enanta Pharmaceuticals ENTA:US $ -32.54M 1.31M
Esperion Therapeutics ESPR:US $ -52376000 9.39M
Gilead Sciences GILD:US $ 2029M 1832M
Intercept Pharmaceuticals ICPT:US $ -13.36M 3.09M
IONIS PHARMACEUT IONS:US $ -85.51M 28.01M
Ironwood Pharmaceuticals IRWD:US $ 55.66M 2.19M
Karyopharm Therapeutics KPTI:US $ -42908000 8.32M
Novartis NOVN:VX 2.23B 624M
Pfizer PFE:US $ 12102M 2229M
Ptc Therapeutics PTCT:US $ -92.36M 5.84M
Puma Biotechnology PBYI:US $ 12M 12.77M
Sangamo Biosciences SGMO:US $ -45.73M 0.47M
Sarepta Therapeutics SRPT:US $ -211.13M 124.25M
Tg Therapeutics TGTX:US $ -38.94M 27.93M
Ultragenyx Pharmaceutical RARE:US $ -141.59M 4.96M
Vertex Pharmaceuticals VRTX:US $ 1106.3M 65.4M
Xencor XNCR:US $ -28M 54.47M
YTE INCY:US $ 254.43M 137.89M